ArticleJournal of neuroinflammation2026
Natural killer cells aggravate neuroinflammation through microglial type I interferon pathway activation after traumatic brain injury.
Article in Journal of neuroinflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Unconventional functions of natural killer cells in homeostasis and disease.Journal of immunology (Baltimore, Md. : 1950) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundTraumatic brain injury (TBI) compromises blood-brain barrier integrity, facilitating infiltration of peripheral immune cells into cerebral tissue. While natural killer (NK) cells - key innate lymphocytes - have been established as critical mediators of secondary neuroinflammation in acute brain injuries including ischemic stroke and intracerebral hemorrhage, their precise involvement in TBI pathophysiology remains undetermined. This study systematically elucidates the role of NK cells in TBI progression and proposes novel immunomodulatory therapeutic strategies for post-TBI intervention.
methodsUsing the controlled cortical impact (CCI) method to generate TBI models, we quantitatively mapped NK cell infiltration patterns through immunofluorescence imaging and flow cytometric analysis. Single-cell RNA sequencing (scRNA-seq) was employed to characterize intracranial-infiltrating NK cells. To delineate NK cell functionality in post-TBI inflammation, we implemented NK1.1 antibody-mediated NK cells depletion followed by multi-modal assessment including: immunofluorescence staining, quantitative real-time polymerase chain reaction (qRT-PCR), flow cytometry, and Western blotting to investigate TBI-induced neuroinflammation; Cortical bulk RNA sequencing to reveal genome-wide transcriptional alterations following NK depletion; And longitudinal evaluation of neurological outcomes using the modified Neurological Severity Score, Morris water maze spatial navigation, and rotarod motor performance tests. Finally, mechanistic insights were further pursued through in vitro neuron-NK cell coculture systems.
resultsIn the CCI model, NK cells rapidly infiltrated the lesion site, reaching peak infiltration density within 12 h post-TBI. Utilizing single-cell RNA sequencing, we performed the first comprehensive characterization of brain-infiltrating NK cells, revealing a unique regulatory phenotype marked by diminished cytotoxic potential (reduced perforin/granzyme B expression), and enhanced cytokine secretory capacity compared to their peripheral blood counterparts. Pseudotemporal reconstruction delineated NK cell differentiation trajectories originating from their peripheral blood counterparts. Crucially, NK cell depletion significantly attenuated TBI-induced neuroinflammation, as evidenced by transcriptomic profiling showing marked suppression of type I interferon (IFN) signaling in the injured cortex. Microglia-specific isolation and analysis localized this inhibitory effect to the IFNAR-STAT1 axis. This finding suggests that NK cells may regulate microglial IFN-I responses potentially through a pathway involving neuronal interferon-beta (IFN-β) secretion. Mechanistic investigations revealed that NK cells potentiate neuronal ER stress through interferon-gamma (IFN-γ) secretion, thereby triggering neuronal IFN-β release.
conclusionNK cells rapidly infiltrate brain lesions following TBI and adopt a regulatory phenotype. NK cell depletion significantly attenuates neurological deficits by suppressing microglial type I IFN signaling pathway. NK cell-derived IFN-γ is correlated with neuronal IFN-β upregulation, suggesting a potential indirect mechanism for amplifying microglial type I IFN responses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.